🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Uterine Cervical Neoplasms

The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site📍 Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. · Tests: Autologous tumor infiltrating lymphocytes (TILs) Intra-lesional Tumor Boost for Bulky Cervical Cancer NCT07435376Phase 21 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: intra-lesional boost IMRT, High Dose Rate Brachytherapy A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) Institut Paoli Calmettes Cervical Cancer Database NCT02869490n/a1 site📍 Marseille Institut Paoli-Calmettes · Tests: Data collection Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). NCT07022470Phase 21 site📍 Palo Alto Stanford University · Tests: 3-Fraction HDR Brachytherapy, 4-Fraction HDR Brachytherapy Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109n/a2 sites📍 Frankfurt am Main📍 Manresa Aesculap AG · Tests: Closure of the Vaginal Cuff after Total Hysterectomy Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer NCT05735145Phase 31 site📍 Liuzhou Fourth Affiliated Hospital of Guangxi Medical University · Tests: paclitaxel combined with platinum A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer NCT07054567Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1, Pembrolizumab, Bevacizumab Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria NCT06751030n/a3 sites📍 Abuja📍 Ibadan📍 Lagos Emory University · Tests: The Mother Mentor program, GeneXpert HPV test A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer NCT07080216Phase 1, Phase 21 site📍 Hangzhou Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Tests: ZG005, Gecacitinib, Bevacizumab A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites📍 Maumee📍 Portland📍 Fairfax TwoStep Therapeutics, Inc. · Tests: TS-104 Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer NCT06140589n/a1 site📍 Fuzhou Fujian Cancer Hospital · Tests: Cadonilimab Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites📍 Beijing📍 Beijing📍 Shanghai GV20 Therapeutics · Tests: GV20-0251 Toripalimab Combined With Definitive CCRT for LACC Patients NCT06256224NA1 site📍 Shanghai Ruijin Hospital · Tests: Toripalimab, CCRT Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study. NCT07400809n/a1 site📍 Mumbai Tata Memorial Hospital · Tests: Not applicable- observational study Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments NCT06799637Phase 1, Phase 224 sites📍 Hefei📍 Hefei📍 Beijing Evopoint Biosciences Inc. · Tests: XNW28012 Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) NCT05475171Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Lorigerlimab Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites📍 Clovis📍 Los Angeles📍 Newport Beach Bristol-Myers Squibb · Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease. NCT06877065n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) NCT06232083Phase 11 site📍 Hefei Anhui Provincial Hospital · Tests: PLDR+Cardunizumab Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy NCT07204535n/a2 sites📍 Pierre-Bénite📍 Strasbourg Centre Paul Strauss · Tests: Prospective questionnaires Serplulimab for Locally Advanced Cervical Cancer NCT07340489Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Serplulimab, radiotherapy, Chemotherapy A Study of Ivonescimab in People With Endometrial and Cervical Cancers NCT06925724Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Ivonescimab Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site📍 Austin Natera, Inc.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy